Cellular Therapy Service
855-776-4224
Call the Mass General Brigham Cancer Institute
Treatment driven by research
At Mass General Brigham Cancer Institute, we bring advances in cell therapy directly into patient care. As leaders in the field, our clinicians and researchers work together to accelerate progress and expand treatment options for people with cancer and other complex and serious diseases, even those that aren’t cancer.
Our long-term goal is to cure disease, while supporting patients today through safe, carefully monitored therapies. We spread these advancements throughout the medical community by providing regular education events in cellular therapy.
Our approach to care
We deliver research-based cellular therapies directly to our patients. Our current offerings and areas of active study include:
- CAR T-cell therapy for lymphoma and multiple myeloma
- Clinical trials evaluating CAR T-cell therapy for glioblastoma
- Tumor-infiltrating lymphocyte (TIL) therapy for melanoma
Conditions and cellular therapies
- Hodgkin Lymphoma
- Leukemia
- Non-Hodgkin Lymphoma
- Multiple Myeloma
- Acute Lymphocytic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Chronic Lymphocytic Leukemia (CLL)
- Aplastic Anemia
- Chronic Myeloid Leukemia (CML)
- CAR T-Cell Therapy for Lymphoma
- Bone Marrow Transplant
- Peripheral Blood Stem Cell Transplant (PBSCT) for Cancer
- Cell Therapy (CAR-T cells)
- Chemotherapy for Lung Cancer
- CAR T-Cell Therapy for Multiple Myeloma
- CAR T-Cell Therapy for Leukemia
Cancer clinical trials and research
Explore our cancer research
Learn how cancer research informs patient care
Search clinical trials
Patient resources and support
View all patient resources
Contact the Cancer Institute
855-776-4224
Call the Mass General Brigham Cancer Institute
International Patient Services
Contact International Patient Services